News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Olinger Margaret
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Gifted 1,580 shares
@ $0 |
|
| 03/20/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 18,333 shares
@ $0
Granted 82,500 options to buy
@ $32.08, valued at
$2.6M
|
|
| 01/10/2023 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,660 shares
@ $36.0789, valued at
$59.9k
Sold 743 shares
@ $36.7888, valued at
$27.3k
|
|
| 01/10/2022 |
4
| Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 28,333 shares
@ $0
Bought 6,842 shares
@ $19, valued at
$130k
Granted 127,500 options to buy
@ $19, valued at
$2.4M
|
|
| 01/06/2022 |
3
| Olinger Margaret (Chief Commercial Officer) has filed a Form 3 on Amylyx Pharmaceuticals, Inc. |
|
|